Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-25-011154
Filing Date
2025-03-07
Accepted
2025-03-07 09:04:34
Documents
98
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K espr-20241231.htm   iXBRL 10-K 2120800
2 EX-19.1 ex-191insidertradingpolicy.htm EX-19.1 76271
3 EX-23.1 ex-231q42024.htm EX-23.1 11446
4 EX-31.1 ex-311q42024.htm EX-31.1 9917
5 EX-31.2 ex-312q42024.htm EX-31.2 10158
6 EX-32.1 ex-321q42024.htm EX-32.1 6213
12 GRAPHIC espr-20241231_g1.jpg GRAPHIC 539259
  Complete submission text file 0001628280-25-011154.txt   11345956

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20241231.xsd EX-101.SCH 82992
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT espr-20241231_cal.xml EX-101.CAL 79574
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT espr-20241231_def.xml EX-101.DEF 383173
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT espr-20241231_lab.xml EX-101.LAB 928241
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20241231_pre.xml EX-101.PRE 657074
101 EXTRACTED XBRL INSTANCE DOCUMENT espr-20241231_htm.xml XML 1130156
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35986 | Film No.: 25717757
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)